ProfileGDS4718 / 40837_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 87% 93% 89% 89% 94% 95% 91% 86% 90% 88% 85% 89% 92% 90% 85% 91% 91% 90% 87% 90% 89% 91% 89% 88% 97% 86% 93% 92% 92% 81% 97% 85% 84% 91% 86% 85% 92% 88% 91% 90% 93% 84% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9335688
GSM549102patient 115, normal, homogenized [OPG study]8.7119287
GSM549104patient 119, normal, homogenized [OPG study]9.8744193
GSM549108patient 138, normal, homogenized [OPG study]8.9835589
GSM549119patient 077, normal, homogenized [OPG study]8.9596389
GSM549133patient 032, cancer, homogenized [OPG study]9.9783994
GSM549139patient 042, cancer, homogenized [OPG study]10.209595
GSM549099patient 107, normal, homogenized [OPG study]9.3513491
GSM549109patient 139, normal, homogenized [OPG study]8.5996486
GSM549110patient 046, normal, homogenized [OPG study]9.2967790
GSM549114patient 063, normal, homogenized [OPG study]9.0582988
GSM549122patient 082, normal, homogenized [OPG study]8.5191285
GSM549134patient 033, cancer, homogenized [OPG study]9.0076889
GSM549136patient 036, cancer, homogenized [OPG study]9.5569292
GSM549140patient 044, cancer, homogenized [OPG study]9.3074590
GSM549111patient 047, normal, homogenized [OPG study]8.5835585
GSM549113patient 057, normal, homogenized [OPG study]9.5438891
GSM549132patient 031, cancer, homogenized [OPG study]9.2486691
GSM549137patient 038, cancer, homogenized [OPG study]9.1917890
GSM549142patient 047, cancer, homogenized [OPG study]8.3898687
GSM549100patient 110, normal, homogenized [OPG study]9.1625990
GSM549107patient 135, normal, homogenized [OPG study]9.1656589
GSM549115patient 068, normal, homogenized [OPG study]9.5902891
GSM549116patient 072, normal, homogenized [OPG study]9.0769389
GSM549120patient 078, normal, homogenized [OPG study]8.8631588
GSM549131patient 030, cancer, homogenized [OPG study]10.810197
GSM549118patient 074, normal, homogenized [OPG study]8.5888686
GSM549129patient 027, cancer, homogenized [OPG study]9.6245893
GSM549123patient 088, normal, homogenized [OPG study]9.5640192
GSM549124patient 006, cancer, homogenized [OPG study]9.466492
GSM549126patient 015, cancer, homogenized [OPG study]7.9605581
GSM549128patient 025, cancer, homogenized [OPG study]10.989897
GSM549103patient 117, normal, homogenized [OPG study]8.3541185
GSM549117patient 073, normal, homogenized [OPG study]8.4158984
GSM549138patient 041, cancer, homogenized [OPG study]9.4248591
GSM549141patient 045, cancer, homogenized [OPG study]8.7373586
GSM549130patient 028, cancer, homogenized [OPG study]8.440185
GSM549101patient 111, normal, homogenized [OPG study]9.4743492
GSM549105patient 128, normal, homogenized [OPG study]8.8112888
GSM549106patient 134, normal, homogenized [OPG study]9.4985191
GSM549112patient 048, normal, homogenized [OPG study]9.1822790
GSM549125patient 011, cancer, homogenized [OPG study]9.685693
GSM549127patient 024, cancer, homogenized [OPG study]8.3549584
GSM549135patient 035, cancer, homogenized [OPG study]10.226395